Avid Bioservices Stock Alpha and Beta Analysis
CDMO Stock | USD 6.68 0.27 4.21% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Avid Bioservices. It also helps investors analyze the systematic and unsystematic risks associated with investing in Avid Bioservices over a specified time horizon. Remember, high Avid Bioservices' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Avid Bioservices' market risk premium analysis include:
Beta 2.11 | Alpha 0.0941 | Risk 6.21 | Sharpe Ratio 0.0242 | Expected Return 0.15 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Avid |
Avid Bioservices Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Avid Bioservices market risk premium is the additional return an investor will receive from holding Avid Bioservices long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Avid Bioservices. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Avid Bioservices' performance over market.α | 0.09 | β | 2.11 |
Avid Bioservices expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Avid Bioservices' Buy-and-hold return. Our buy-and-hold chart shows how Avid Bioservices performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Avid Bioservices Market Price Analysis
Market price analysis indicators help investors to evaluate how Avid Bioservices stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avid Bioservices shares will generate the highest return on investment. By understating and applying Avid Bioservices stock market price indicators, traders can identify Avid Bioservices position entry and exit signals to maximize returns.
Avid Bioservices Return and Market Media
The median price of Avid Bioservices for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 is 6.74 with a coefficient of variation of 9.04. The daily time series for the period is distributed with a sample standard deviation of 0.63, arithmetic mean of 6.92, and mean deviation of 0.5. The Stock received a lot of media exposure during the period. Price Growth (%) |
Timeline |
1 | AVID ALERT Bragar Eagel Squire, P.C. is Investigating Avid Bioservices, Inc. on Behalf of Avid Stockholders and Encourages Investors to Contact the Firm | 03/08/2024 |
2 | Microbixs Clot-Buster Drug Project Advances | 03/14/2024 |
3 | Global Contract Development and Manufacturing Organization Research Report 2024 Vendors are Anticipated to Concentrate on Offering One-Stop-Shop Services to Gai... | 03/22/2024 |
4 | Riassunto PCI Pharma Services, una delle principali CDMO, pubblica un report completo sui problemi ESG | 03/28/2024 |
5 | Avid Bioservices Falls Further After Disclosing Intent to Restate Financial Statements Due to Misclassification of 146 Million of 2026 Notes as Long-Term Liabil... | 04/01/2024 |
6 | What do analysts say about Avid Bioservices | 04/02/2024 |
7 | How much will Avid Bioservices owe in May | 04/04/2024 |
8 | CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc. | 04/08/2024 |
9 | Acquisition by Green Nicholas Stewart of 5573 shares of Avid Bioservices subject to Rule 16b-3 | 04/09/2024 |
10 | Acquisition by Matthew Kwietniak of 669 shares of Avid Bioservices subject to Rule 16b-3 | 04/11/2024 |
11 | Disposition of 669 shares by Matthew Kwietniak of Avid Bioservices subject to Rule 16b-3 | 04/12/2024 |
12 | Avid Bioservices Set to Join SP SmallCap 600 - The Globe and Mail | 04/15/2024 |
13 | Evergreen Theragnostics Completes 26M Capital Raise to Advance Novel Radiopharmaceutical Pipeline into the Clinic, Prepare for First Commercial Product Launch, ... | 04/16/2024 |
14 | Mithra secures court protection measures to advance monetization process | 04/22/2024 |
About Avid Bioservices Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Avid or other stocks. Alpha measures the amount that position in Avid Bioservices has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
2023 | 2024 (projected) | Dividend Yield | 0.003217 | 0.003056 | Price To Sales Ratio | 8.52 | 8.09 |
Avid Bioservices Upcoming Company Events
As portrayed in its financial statements, the presentation of Avid Bioservices' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Avid Bioservices' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Avid Bioservices' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Avid Bioservices. Please utilize our Beneish M Score to check the likelihood of Avid Bioservices' management manipulating its earnings.
11th of March 2024 Upcoming Quarterly Report | View | |
19th of June 2024 Next Financial Report | View | |
31st of January 2024 Next Fiscal Quarter End | View | |
19th of June 2024 Next Fiscal Year End | View | |
31st of October 2023 Last Quarter Report | View | |
30th of April 2023 Last Financial Announcement | View |
Build Portfolio with Avid Bioservices
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Avid Bioservices Backtesting, Avid Bioservices Valuation, Avid Bioservices Correlation, Avid Bioservices Hype Analysis, Avid Bioservices Volatility, Avid Bioservices History and analyze Avid Bioservices Performance. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Avid Stock analysis
When running Avid Bioservices' price analysis, check to measure Avid Bioservices' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avid Bioservices is operating at the current time. Most of Avid Bioservices' value examination focuses on studying past and present price action to predict the probability of Avid Bioservices' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avid Bioservices' price. Additionally, you may evaluate how the addition of Avid Bioservices to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Avid Bioservices technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.